Could a softer Heart-Lung machine protect the brain during surgery?

NCT ID NCT07661238

Ongoing Knowledge-focused Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a newer, less invasive heart-lung machine (MiECC) reduces brain swelling and stroke risk compared to the standard machine used during open heart surgery. Researchers will measure optic nerve sheath diameter (a marker of brain pressure) and track strokes over 30 days in 100 adults undergoing elective heart surgery. The goal is to see if MiECC offers better brain protection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Minimally Invasive Extracorporeal Circulation (MiECC)
What this could lead to: If MiECC reduces brain-related complications like stroke or swelling, it could become a safer standard for heart surgery.
What could go wrong: This is a single-center trial with 100 participants, so results may not apply broadly. The study measures early signs, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY CARDIOPULMONARY BYPASS STROKE

Contacts and locations

Locations

University of Health Sciences Bursa Yüksek Ihtisas Training and Research Hospital

Bursa, Yıldırım, 16600, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.